RNA content in the nucleolus alters p53 acetylation via MYBBP1A

EMBO Journal

Volumn 30, Issue 6, 2011, Pages 1054-1066

  Kuroda, Takao ^a   Murayama, Akiko ^a,b   Katagiri, Naohiro ^a   Ohta, Yu Mi ^a   Fujita, Etsuko ^a   Masumoto, Hiroshi ^a   Ema, Masatsugu ^a   Takahashi, Satoru ^a   Kimura, Keiji ^a   Yanagisawa, Junn ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

MYBBP1A; nucleolar disruption; p53; RPL11; RPL5

Indexed keywords

NUCLEAR PROTEIN; NUCLEOPLASMIN; PROTEIN MYBBP1A; PROTEIN P300; PROTEIN P53; PROTEIN RPL11; PROTEIN RPL5; RIBOSOME RNA; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA ANALYSIS; RNA TRANSCRIPTION;

ACETYLATION; CELL LINE; CELL NUCLEOLUS; HUMANS; NUCLEAR PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952742986     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2011.23     Document Type: Article

References (101)

1. Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M (2005) Nucleolar proteome dynamics. Nature 433: 77-83 (Pubitemid 40101146)
2. Appella E, Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772 (Pubitemid 32862957)
3. Arva NC, Gopen TR, Talbott KE, Campbell LE, Chicas A, White DE, Bond GL, Levine AJ, Bargonetti J (2005) A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells. J Biol Chem 280: 26776-26787 (Pubitemid 41040711)
4. Ashcroft M, Kubbutat MH, Vousden KH (1999) Regulation of p53 function and stability by phosphorylation. Mol Cell Biol 19: 1751-1758 (Pubitemid 29098233)
5. Ashcroft M, Taya Y, Vousden KH (2000) Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol 20: 3224-3233 (Pubitemid 30215034)
6. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8: 1243-1254 (Pubitemid 34084996)
7. Bhat KP, Itahana K, Jin A, Zhang Y (2004) Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J 23: 2402-2412 (Pubitemid 38954847)
8. Blattner C, Tobiasch E, Litfen M, Rahmsdorf HJ, Herrlich P (1999) DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene 18: 1723-1732 (Pubitemid 29137463)
9. Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805 (Pubitemid 39331151)
10. Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171 (Pubitemid 36332191)
11. Brooks CL, Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21 : 307-315 (Pubitemid 43163526)
12. Carter S, Vousden KH (2009) Modifications of p53: competing for the lysines. Curr Opin Genet Dev 19: 18-24
13. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD (1999) Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 96: 13777-13782
14. Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, Hill DL, Wang H, Zhang R (2007) Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 26: 5029-5037 (Pubitemid 47206956)
15. Dai MS, Lu H (2004) Inhibition of MDM2-mediated p53 ubiquitina-tion and degradation by ribosomal protein L5. J Biol Chem 279: 44475-44482 (Pubitemid 39430853)
16. Dai MS, Sun XX, Lu H (2008) Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol 28: 4365-4376 (Pubitemid 351904958)
17. Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H (2004) Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 24: 7654-7668 (Pubitemid 39121491)
18. Das S, Raj L, Zhao B, Kimura Y, Bernstein A, Aaronson SA, Lee SW (2007) Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 130: 624-637 (Pubitemid 47277418)
19. Dechampesme AM, Koroleva O, Leger-Silvestre I, Gas N, Camier S (1999) Assembly of 5S ribosomal RNA is required at a specific step of the pre-rRNA processing pathway. J Cell Biol 145: 1369-1380 (Pubitemid 29309996)
20. Diaz VM, Mori S, Longobardi E, Menendez G, Ferrai C, Keough RA, Bachi A, Blasi F (2007) p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity. Mol Cell Biol 27: 7981-7990 (Pubitemid 350086430)
21. Dousset T, Wang C, Verheggen C, Chen D, Hernandez-Verdun D, Huang S (2000) Initiation of nucleolar assembly is independent of RNA polymerase I transcription. Mol Biol Cell 11 : 2705-2717 (Pubitemid 30645037)
22. Dumaz N, Meek DW (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18: 7002-7010 (Pubitemid 30000453)
23. Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J, Jaeger S, Erdjument-Bromage H, Tempst P, Spiegelman BM (2004) Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. Genes Dev 18: 278-289 (Pubitemid 38199253)
24. Favier D, Gonda TJ (1994) Detection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene 9: 305-311 (Pubitemid 24020963)
25. Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, Mihara M, Naitou M, Endoh H, Nakamura T, Akimoto C, Yamamoto Y, Katagiri T, Foulds C, Takezawa S, Kitagawa H, Takeyama K, O'Malley BW, Kato S (2007) DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 9: 604-611 (Pubitemid 46696543)
26. Gonda K, Fowler J, Katoku-Kikyo N, Haroldson J, Wudel J, Kikyo N (2003) Reversible disassembly of somatic nucleoli by the germ cell proteins FRGY2a and FRGY2b. Nat Cell Biol 5: 205-210 (Pubitemid 36322246)
27. Gonda K, Wudel J, Nelson D, Katoku-Kikyo N, Reed P, Tamada H, Kikyo N (2006) Requirement of the protein B23 for nucleolar disassembly induced by the FRGY2a family proteins. J Biol Chem 281: 8153-8160 (Pubitemid 43847434)
28. Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6: 493-505 (Pubitemid 43980539)
29. Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606 (Pubitemid 27357952)
30. Gustafson WC, Taylor CW, Valdez BC, Henning D, Phippard A, Ren Y, Busch H, Durban E (1998) Nucleolar protein p120 contains an arginine-rich domain that binds to ribosomal RNA. Biochem J 331 (Pt 2): 387-393 (Pubitemid 28182150)
31. Hara Y, Onishi Y, Oishi K, Miyazaki K, Fukamizu A, Ishida N (2009) Molecular characterization of Mybbp1a as a co-repressor on the Period2 promoter. Nucleic Acids Res 37: 1115-1126
32. Hirano Y, Ishii K, Kumeta M, Furukawa K, Takeyasu K, Horigome T (2009) Proteomic and targeted analytical identification of BXDC1 and EBNA1BP2 as dynamic scaffold proteins in the nucleolus. Genes Cells 14: 155-166
33. Homer C, Knight DA, Hananeia L, Sheard P, Risk J, Lasham A, Royds JA, Braithwaite AW (2005) Y-box factor YB1 controls p53 apoptotic function. Oncogene 24: 8314-8325 (Pubitemid 43250923)
34. Horn HF, Vousden KH (2008) Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 27: 5774-5784
35. Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E, Yao TP (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21 : 6236-6245 (Pubitemid 35415340)
36. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, Yao TP (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20: 1331-1340 (Pubitemid 32233973)
37. Jin A, Itahana K, O'Keefe K, Zhang Y (2004) Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24: 7669-7680 (Pubitemid 39121492)
38. Jones LC, Okino ST, Gonda TJ, Whitlock Jr JP (2002) Myb-binding protein 1a augments AhR-dependent gene expression. J Biol Chem 277: 22515-22519 (Pubitemid 34967225)
39. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA 95: 8292-8297 (Pubitemid 28326106)
40. Kim JE, Chen J, Lou Z (2008) DBC1 is a negative regulator of SIRT1. Nature 451: 583-586 (Pubitemid 351186264)
41. Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A, Quong AA, Zhang X, Beerman T, Pestell RG, Avantaggiati ML (2006) Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 173: 533-544 (Pubitemid 43765200)
42. Krummel KA, Lee CJ, Toledo F, Wahl GM (2005) The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci USA 102: 10188-10193 (Pubitemid 41023347)
43. Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137: 609-622
44. Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, Laiho M (2004) Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5: 465-475 (Pubitemid 38610248)
45. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN (1998) Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem 273: 33048-33053 (Pubitemid 28557701)
46. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331 (Pubitemid 27131374)
47. Li AG, Piluso LG, Cai X, Gadd BJ, Ladurner AG, Liu X (2007) An acetylation switch in p53 mediates holo-TFIID recruitment. Mol Cell 28: 408-421 (Pubitemid 350030559)
48. Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611 (Pubitemid 36042220)
49. Lindstrom MS, Jin A, Deisenroth C, White Wolf G, Zhang Y (2007) Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-in-duced p53 degradation. Mol Cell Biol 27: 1056-1068 (Pubitemid 46174567)
50. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3: 577-587 (Pubitemid 36808652)
51. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101 : 2259-2264 (Pubitemid 38269299)
52. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107 : 137-148 (Pubitemid 33035941)
53. Luo J, Su F, Chen D, Shiloh A, Gu W (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381
54. Marechal V, Elenbaas B, Piette J, Nicolas JC, Levine AJ (1994) The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol 14: 7414-7420 (Pubitemid 24326406)
55. Mayer C, Bierhoff H, Grummt I (2005) The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis. Genes Dev 19: 933-941 (Pubitemid 40548061)
56. Mayer C, Grummt I (2005) Cellular stress and nucleolar function. Cell Cycle 4: 1036-1038 (Pubitemid 41365359)
57. Michael D, Oren M (2003) The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13: 49-58 (Pubitemid 36269180)
58. Minsky N, Oren M (2004) The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell 16: 631-639 (Pubitemid 39531885)
59. 0-extension of 5S rRNA in Saccharomyces cerevisiae. Nucleic Acids Res 33: 4553-4562 (Pubitemid 41222570)
60. Ohkubo S, Tanaka T, Taya Y, Kitazato K, Prives C (2006) Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. J Biol Chem 281: 16943-16950
61. Olsson A, Manzl C, Strasser A, Villunger A (2007) How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 14: 1561-1575 (Pubitemid 47278842)
62. Owen HR, Elser M, Cheung E, Gersbach M, Kraus WL, Hottiger MO (2007) MYBBP1a is a novel repressor of NF-kappaB. J Mol Biol 366: 725-736
63. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723 (Pubitemid 28155311)
64. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187: 112-126 (Pubitemid 29009841)
65. Rubbi CP, Milner J (2003) Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22: 6068-6077 (Pubitemid 37463250)
66. Saavalainen K, Pasonen-Seppanen S, Dunlop TW, Tammi R, Tammi MI, Carlberg C (2005) The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. J Biol Chem 280: 14636-14644 (Pubitemid 40562809)
67. Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace Jr AJ, Appella E, Anderson CW (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 278: 37536-37544 (Pubitemid 37175275)
68. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E (1998) DNA damage activates p53 through a phosphorylation- acetylation cascade. Genes Dev 12: 2831-2841 (Pubitemid 28440142)
69. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8: 781-794 (Pubitemid 33030212)
70. Saramaki A, Banwell CM, Campbell MJ, Carlberg C (2006) Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34: 543-554 (Pubitemid 43240242)
71. Saxena A, Rorie CJ, Dimitrova D, Daniely Y, Borowiec JA (2006) Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization. Oncogene 25: 7274-7288 (Pubitemid 44809093)
72. Scheer U, Hock R (1999) Structure and function of the nucleolus. Curr Opin Cell Biol 11 : 385-390 (Pubitemid 29273811)
73. Schwarzacher HG, Wachtler F (1993) The nucleolus. Anat Embryol (Berl) 188: 515-536 (Pubitemid 24036862)
74. Shieh SY, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334 (Pubitemid 27467963)
75. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11 : 3471-3481 (Pubitemid 28023968)
76. Sinkkonen L, Malinen M, Saavalainen K, Vaisanen S, Carlberg C (2005) Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. Nucleic Acids Res 33: 2440-2451 (Pubitemid 41511263)
77. Spierer P, Zimmermann RA (1978) Stoichiometry, cooperativity, and stability of interactions between 5S RNA and proteins L5, L18, and L25 from the 50S ribosomal subunit of Escherichia coli. Biochemistry 17: 2474-2479 (Pubitemid 8363353)
78. Steitz JA, Berg C, Hendrick JP, La Branche-Chabot H, Metspalu A, Rinke J, Yario T (1988) A 5S rRNA/L5 complex is a precursor to ribosome assembly in mammalian cells. J Cell Biol 106: 545-556 (Pubitemid 18089955)
79. Takenaka I, Morin F, Seizinger BR, Kley N (1995) Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem 270: 5405-5411
80. Tanaka T, Ohkubo S, Tatsuno I, Prives C (2007) hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell 130: 638-650 (Pubitemid 47268061)
81. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W (2008) Acetylation is indispensable for p53 activation. Cell 133: 612-626 (Pubitemid 351636297)
82. Tavner FJ, Simpson R, Tashiro S, Favier D, Jenkins NA, Gilbert DJ, Copeland NG, Macmillan EM, Lutwyche J, Keough RA, Ishii S, Gonda TJ (1998) Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb. Mol Cell Biol 18: 989-1002 (Pubitemid 28063433)
83. Thiry M, Lamaye F, Thelen N, Chatron-Colliet A, Lalun N, Bobichon H, Ploton D (2008) A protocol for studying the kinetics of RNA within cultured cells: application to ribosomal RNA. Nat Protoc 3: 1997-2004
84. Thompson T, Tovar C, Yang H, Carvajal D, Vu BT, Xu Q, Wahl GM, Heimbrook DC, Vassilev LT (2004) Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apopto-sis. J Biol Chem 279: 53015-53022 (Pubitemid 40051800)
85. Tian C, Xing G, Xie P, Lu K, Nie J, Wang J, Li L, Gao M, Zhang L, He F (2009) KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol 11 : 580-591
86. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 13: 152-157 (Pubitemid 29061945)
87. Trigiante G, Lu X (2006) ASPP and cancer. Nat Rev Cancer 6: 217-226
88. Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G, Oren M, Haupt Y (1999) Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J 18: 1805-1814 (Pubitemid 29158524)
89. Van Ryk DI, Lee Y, Nazar RN (1992) Unbalanced ribosome assembly in Saccharomyces cerevisiae expressing mutant 5 S rRNAs. J Biol Chem 267: 16177-16181
90. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107 : 149-159 (Pubitemid 33035942)
91. Verheggen C, Almouzni G, Hernandez-Verdun D (2000) The ribo-somal RNA processing machinery is recruited to the nucleolar domain before RNA polymerase I during Xenopus laevis development. J Cell Biol 149: 293-306
92. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283 (Pubitemid 46474662)
93. Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137: 413-431
94. Wei X, Xu H, Kufe D (2005) Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 7: 167-178 (Pubitemid 40248342)
95. Wu Z, Earle J, Saito S, Anderson CW, Appella E, Xu Y (2002) Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol 22: 2441-2449 (Pubitemid 34262967)
96. Yamauchi T, Keough RA, Gonda TJ, Ishii S (2008) Ribosomal stress induces processing of Mybbp1a and its translocation from the nucleolus to the nucleoplasm. Genes Cells 13: 27-39
97. Yuan X, Zhou Y, Casanova E, Chai M, Kiss E, Grone HJ, Schutz G, Grummt I (2005) Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol Cell 19: 77-87 (Pubitemid 40884659)
98. Zhang J, Harnpicharnchai P, Jakovljevic J, Tang L, Guo Y, Oeffinger M, Rout MP, Hiley SL, Hughes T, Woolford Jr JL (2007) Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes Dev 21: 2580-2592 (Pubitemid 47607669)
99. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23: 8902-8912 (Pubitemid 37433388)
100. Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W (2008) Negative regulation of the deacetylase SIRT1 by DBC1. Nature 451: 587-590 (Pubitemid 351186268)
101. Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X, Prives C (2009) Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 35: 316-326